Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
06/2004
06/24/2004US20040122074 1-[5-(4-chloro-phenyl)-1-(2-chloro-phenyl)-4-methyl-1H-pyrazol-3-yl]-2-piperidin-1-yl-ethanone,e.g. as antagonist or inverse agonists; nicotine partial agonist; an opioid antagonist; a dopaminergic agent; an attention deficit disorder agent
06/24/2004US20040122062 such as 2-amino-N-(2-(3a-(R)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-pyrazolo-[4,3-c]pyridin-5-yl)-1-(R)-benzyloxymethyl-2-oxo-ethyl)-isobutyramide
06/24/2004US20040122053 2-(substituted-phenyl)amino-imidazoline derivatives
06/24/2004US20040122046 NPY-5 antagonists
06/24/2004US20040122026 N-[2-Methyl-3-(piperidinomethyl)phenyl]-3-[3-(3,5-dichlorobenzyl)-2-dicyanomethylidene imidazolidin-1-yl]propionamide for example; autoimmune or allergic diseases
06/24/2004US20040122009 formed via cyanuric chloride; for treatment of cancer and proliferative diseases
06/24/2004US20040121989 Renal-selective biphenylalkyl 1H-substituted-1,2,4-triazole angiotensin II antagonists for treatment of hypertension
06/24/2004US20040121964 For prophylaxis and therapy of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases
06/24/2004US20040121316 Method and compositions for identifying anti-HIV therapeutic compounds
06/24/2004DE69233189T2 Heteroarylpiperidine-pyrrolidine und piperazine und ihre anwendung als antipsychotisches und analgetisches mittel Heteroarylpiperidines-pyrrolidine and piperazine and its application as an antipsychotic and analgesic medium
06/24/2004CA2509222A1 Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
06/24/2004CA2508788A1 3-pyrrolyl urea derivatives and their use as antiviral agents
06/24/2004CA2508769A1 Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif
06/24/2004CA2508452A1 Triazine compounds and their use in forming multidimensional libraries for affinity chromatography
06/24/2004CA2508170A1 Pyrazine-based tubulin inhibitors
06/24/2004CA2508010A1 3-phenyl-cinnoline analogue and antitumor agent using the same
06/24/2004CA2505887A1 Pyrazole and imidazole compounds and uses thereof
06/23/2004EP1431286A2 Prodigiosin derivatives for treating cancer or viral diseases
06/23/2004EP1430120A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
06/23/2004EP1430102A1 Cationic reactive dyes
06/23/2004EP1430048A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
06/23/2004EP1430047A1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
06/23/2004EP1430034A1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
06/23/2004EP1430033A1 Anti-inflammatory and protein kinase inhibitor composition and method of use
06/23/2004EP1430032A2 Substituted amides for the treatment of neurological disorders
06/23/2004EP1430028A2 Aromatic and heteroaromatic acid halides for synthesizing polyamides
06/23/2004EP1429773A1 Process for making substituted pyrazoles
06/23/2004EP1429765A2 Inhibitors of histone deacetylase
06/23/2004EP1429763A2 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER
06/23/2004EP1429762A1 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity
06/23/2004EP1429761A1 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
06/23/2004EP1429759A2 Compounds useful for treating hepatitus c virus
06/23/2004EP1255753B1 Prodigiosin-derivatives as neoplastic and anti-viral agents
06/23/2004EP1252157B1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
06/23/2004EP1251848B1 Gyrase inhibitors and uses thereof
06/23/2004EP1246817B1 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
06/23/2004EP0983251B1 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof
06/23/2004EP0942904B1 3-thiocarbamoylpyrazole derivatives as pesticides
06/23/2004CN1507436A Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers
06/23/2004CN1507435A Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
06/23/2004CN1154642C Pyranone compounds useful to treat retroviral infections
06/23/2004CN1154641C Anti-cancer medicine 3,6-dimethyl 1,4-dihydro 1,2,4,5-tetrazine-1,4-dimethyl amides compound and preparation process thereof
06/22/2004US6753425 Bis(2,6-diaminotriazin-4- yl)arylenediamine derivative having sulfonic acid, carboxylic, and/or hydroxyl group; silver halide color photographic light-sensitive materials; discoloration inhibition; antisoilants
06/22/2004US6753332 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
06/22/2004US6753331 Heterocyclic derivatives which inhibit factor Xa
06/22/2004US6753329 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
06/22/2004US6753316 Acryloyl derivatives analogous to distamycin, process for preparing them, and their use as antitumor agents
06/17/2004WO2004050653A2 Oxime ester photoinitiators with heteroaromatic groups
06/17/2004WO2004050651A1 Anilinopyrazole derivatives useful for the treatment of diabetes
06/17/2004WO2004050650A1 Anilinopyrazole derivatives useful for the treatment of diabetes
06/17/2004WO2004050643A2 Non-nucleoside reverse transcriptase inhibitors
06/17/2004WO2004050642A1 1, 2, 3- triazole amide derivatives as cytokine inhibitors
06/17/2004WO2004050637A2 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
06/17/2004WO2004050633A1 Pesticidal 1-ayl-3-amidoxime-pyrazole derivatives
06/17/2004WO2004050632A1 Pyrazole derivatives useful as cox-i inhibitors
06/17/2004WO2004050623A1 Methods for preparing phenylalkyne derivatives
06/17/2004WO2004050621A2 Indol derivatives and their use as kinase inhibitors
06/17/2004WO2004050619A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease
06/17/2004WO2004050085A1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders
06/17/2004WO2004050084A2 Ace-inhibitors having antioxidant and nitricoxid-donor activity
06/17/2004WO2004050039A2 Spirocyclic ureas, compositions containing such compounds and methods of use
06/17/2004WO2004050035A2 Benzimidazoles and analogs thereof as antivirals
06/17/2004WO2004050024A2 3-aminopyrrolidine derivatives as modulators of chemokine receptors
06/17/2004WO2004049797A2 Pesticidal sulphonylaminopyrazoles
06/17/2004WO2004031176A3 Delta1 pyrrolines used as pesticides
06/17/2004WO2004018414A3 Antibacterial agents
06/17/2004WO2004014869A3 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors
06/17/2004US20040116710 N3 alkylated benzimidazole derivatives as MEK inhibitors
06/17/2004US20040116699 Melanocortin receptor agonists
06/17/2004US20040116695 2-Mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors
06/17/2004US20040116507 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
06/17/2004US20040116504 Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
06/17/2004US20040116499 treatment of inflammatory or proliferative diseases of the skin and other organ systems; from yeast of the genus Malassezia; for example, 2,3-dihydro-4,5-bis(indol-3-yl)furan-2,3-dione; against multiresistent staphylococci
06/17/2004US20040116491 Therapy for infections; autoimmune diseases; vision defects; asthma:eating disorders; cardiovascular disorders; liver disorders; antiallergens; antiinflammatory agents; antiulcer agnets
06/17/2004US20040116486 Metalloproteinase inhibitors
06/17/2004US20040116475 Nitrogen compounds such as N-(2-{4-[3-chloro-1-(4-methoxyphenyl)-1-H-pyrazol-5-yl]-phenoxy}ethyl)urea, used as cyclooxygenase inhibitors; analgesics; antiinflammatory agents
06/17/2004US20040116467 Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
06/17/2004US20040116465 Novel compounds
06/17/2004US20040116454 Pyrazole compounds useful as protein kinase inhibitors
06/17/2004US20040116443 Dopamine D4 ligands for the treatment of novelty-seeking disorders
06/17/2004US20040116429 5-Phenylpyrimidines, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi
06/17/2004US20040116424 Aryl imidazoles and related compounds as C5a receptor modulators
06/17/2004US20040116423 5-Aryltetrazole compounds, compositions thereof, and uses therefor
06/17/2004US20040116421 Heterocyclic compounds as antitumor agents with benzimidazole group and morpholine group, triazoline or pyrimidine heterocycles
06/17/2004US20040116420 Remedial agent for viral infectious disease
06/17/2004US20040116417 Thiohydantoins and use thereof for treating diabetes
06/17/2004US20040116399 for preventing or treating coagulation disorders
06/17/2004US20040116388 triazine compoound inhibitors of enzymes that catalyze phosphoryl transfer and/or that bind ATP/GTP nucleotides
06/17/2004US20040115821 Sequestering proteins, peptides; determination concentration in mixture; analyzing by mass spectroscopy
06/17/2004DE10256405A1 New 4-substituted quinoline derivatives, useful for treating bacterial infections, optionally including additional ring nitrogens
06/17/2004DE10247233A1 New 4-substituted quinoline derivatives, useful for treating bacterial infections, optionally including additional ring nitrogens
06/17/2004CA2508581A1 Spirocyclic ureas, compositions containing such compounds and methods of use
06/17/2004CA2508325A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease
06/17/2004CA2508315A1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders
06/17/2004CA2507875A1 Methods for preparing phenylalkyne derivatives
06/17/2004CA2507780A1 Indol derivatives and their use as kinase inhibitors
06/17/2004CA2507186A1 Anilinopyrazole derivatives useful for the treatment of diabetes
06/17/2004CA2505945A1 Pyrazole derivatives useful as cox-i inhibitors
06/17/2004CA2505893A1 Oxime ester photoinitiators with heteroaromatic groups
06/16/2004EP1429147A1 Universal reagent for isotopically tagging peptides